What motivation science has to say about goodbyes. Plus, GE’s $1.45 billion acquisition and monoclonal antibody bottleneck. Read More
Related Articles
20 Things That Went Strangely, Wonderfully Right in 2020
So long, annus horribilis. Farewell, O rotten plague year. Dominus vobiscum. But as we utter our long-practiced goodbyes to 2020, let us pause for a moment to reflect upon the glad tidings that lay hidden in its miasmic haze. Yes, surprising as it may seem, there were some things that turned out darn well in […]
Bitcoin, IPOs, and post-pandemic travel—here’s what tech CEOs are saying at Fortune Global Forum
The bosses of Airbnb, Cisco, Microstrategy, and Nasdaq had much to say at Fortune’s marquee conference this year. Read More
‘An operator:’ What to know about Roz Brewer, Walgreens’ new CEO
Good morning, Broadsheet readers! Women leaders call for a Marshall Plan for Moms, Aetna will cover a wide range of procedures for trans women, and Roz Brewer is Walgreens’ new CEO. Have an excellent Wednesday. – Shot in the arm. For years now, many companies on the Fortune 500 have tried to cast themselves as […]